Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon
ISS Joins Glass Lewis, Egan-Jones, and Long-Term Shareholders in Opposing Proposed Transaction Concludes There Is No Compelling Reason for Shareholders to Support Proposed Sale of STAAR Broadwood Cautions STAAR's Board Against Making Further Significant Decis
(Financial Post, 2025-10-15T17:44:39Z)